Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Inattention treatment

This account of debit and credit is given here, as an honest attempt at the attenuation of that grossly inattentive treatment with what the early history of a noble institution was dealt with [2290]. To those who still remember Clifton Dexter Howe, or read about the work conducted, and the original observations made at The Section at the DM, which pre-dated their time in medical history, but eventually turned out to be all correct ( OK ) Their advocacy is highly appreciated ... [Pg.552]

There is not an empirically proven threshold of ADHD symptoms that can guide the decision about whether a particular child should be started on a stimulant, or what the initial dosage should be. Only those patients with moderate to severe impairment should be considered. Even though children diagnosed with ADD, predominantly inattentive type, might not experience impairment socially or at home, they may benefit academically from stimulant treatment. To qualify for stimulant treatment, the child must be living with a responsible adult who can administer the medication. In the case of multiple daily dosing schedules, it is necessary for school personnel to administer the mid-day dose. [Pg.259]

The Multimodal Treatment of ADHD (MTA) Study, a large, multisite study of ADHD treatment (MTA Cooperative Group, 1999), highlights the importance of this therapeutic alliance. When outcome was measured only in terms of the child s inattention, stimulant medication alone did as well as medication plus psychosocial treatment. However, the combination of medication and psychotherapy had the best outcome in parent satisfaction and in reducing disruptive behaviors (Hinshaw et ah, 2000), which are important factors in longer-term compliance with treatment and outcome. [Pg.398]

Inattentiveness, impulsivity, hyperactivity 50% will continue to manifest the disorder into adulthood Stimulants (70% response for uncomplicated ADHD caution in patients with tic disorders) TCAs (70% response, first line for patients with comorbid MD or anxiety disorders, and for patients with ADHD + tics) requires serum levels and cardiovascular monitoring Bupropion Clonidine, guan-facine (first line for patients with ADHD + tics) MAOIs Combined pharmacotherapy for treatment-resistant cases... [Pg.452]

Drugs that have primary effects on the core social impairment of autistic disorder and other PDDs have not yet been developed. Currently, the pharmacotherapy of this group of disorders involves the identification and treatment of associated symptoms, including motor hyperactivity, inattention, irritability, aggression toward self, others, or the environment, and interfering repetitive thoughts and behavior. Improvement in some aspects of social behavior can occur as a result of a reduction in these associated target symptoms. [Pg.563]

Safer, D.J. and Krager, J.M. (1988) A survey of medication treatment for hyperactive/inattentive students./AMA 260 2256-2258. [Pg.711]

In children and adolescents, the decision to medicate is based on problems with inattention, impulsivity, and hyperactivity that are persistent and sufficiently severe to cause functional impairment at school, at home, and with peers. Before treatment with psychostimulants is instituted, other treatable causes should be ruled out and behavioral interventions considered. To maximize the likelihood of successful treatment with psychostimulants, parents or guardians should be involved in the treatment plan, including monitoring the administration of the medication, learning new disciplinary techniques, and participating in the patient s follow-up appointments (42). [Pg.277]

Ideally, assessment measures would be incorporated into the treatment plan to assess baseline symptoms and response to treatment. Such measures include the Clinical Global Impression (CGI) scale, the ten-item Conners Global Index for parents (Conners-P) and Teachers (Conners-T) ( 60), and the SNAP (Swanson, Nolan, and Pelham) rating scale (61). The latter has also been used in surveys of school-aged children ( 62). The results have been used to produce age-adjusted cutoffs that distinguish normal from abnormal degrees of inattentiveness and hyperactive/impulsive behavior. Thus, this scale can also be used to aid in documentation of the diagnosis as well as to monitor response to treatment. [Pg.277]

The combination was reported to be superior to either agent alone in reducing parent ratings of conduct problems. However, the combination has never been tested in children with ADHD alone for the core symptoms of hyperactivity, inattention, and impulsivity. There is also concern about the safety of this combination because there have been four deaths in children (105). However, there were enough complicating factors present in each of these cases that no conclusions could be drawn about the role of methylphenidate and clonidine in these deaths. For these reasons, the use of clonidine for the treatment of ADHD should be tried only after trials of more than one psychostimulant and after an antidepressant trial. [Pg.279]

Children with ADHD are inattentive, impulsive, and hyperactive. The areas of their brains that control attention and restraint do not function properly. Stimulant drugs, specifically amphetamines, have been used in the United States to treat children with inattention and hyperactivity disorders since the 1930s. MPH was also discovered to have a calming effect on hyperactive children and a focusing effect on those with attention deficit disorder (ADD). However, it was not until the 1960s that the U.S. Food and Drug Administration (FDA) approved methylphenidate for the treatment of ADHD. At the turn of the twenty-first century, approximately 90% of all methylphenidate was prescribed for ADHD children. Most of the rest was prescribed to treat adults with a sleeping sickness known as narcolepsy. [Pg.349]

A piperidine derivative, methylphenidate facilitates the release of catecholamines and blocks their reuptake and degradation (27). It is considered to be a mild central nervous system (CNS) stimulant, which appears to stimulate brain structures in a manner similar to amphetamines (26). A strongly favored treatment for ADHD, methylphenidate prescriptions account for over 90% of prescription stimulants used in the United States (28). Both children and adults who have been diagnosed with ADHD have been treated with methylphenidate with a high degree of success (29,30). A review of the studies in which stimulants were used by children with ADHD indicated significant evidence for improvement in hyperactivity, inattention, and impulsivity (28). [Pg.391]

Specific learning disabilities and gaps in knowledge and skills due to inattention require educational remediation. Social skills deficit and family pathology may need specific treatment. Parent education and... [Pg.285]

In a study of extended treatment (15 months) of ADHD, amfetamine was clearly superior to placebo in reducing inattention, hyperactivity, and other disruptive behavioral problems. The treatment failure rate was considerably lower and the time to treatment failure was longer in the treated group adverse effects were few and relatively mild (11). [Pg.454]

Treatment with galantamine has been shown to increase verbal fluency (Hertzman, 2003), improve emotional lability and inattention (Nicholson et al.,... [Pg.387]

The goai of treatment of ADHD is reducfion of symptoms of inattentiveness, motor hyperactivity, and/or impuisiveness that disrupt sociai, schooi, and/or occupationai functioning... [Pg.31]

The goal ot treatment of ADHD is reduction ot symptoms ot inattentiveness, motor hyperactivity, and/or impulsiveness that disrupt social, school, and/or occupational tunctioning... [Pg.357]

An example from our own laboratory is the methylphenidate bioanalyti-cal chiral LC-MS/MS assay in support of toxicokinetics (TK) and PK studies (vide infra). Attention-deflcit hyperactivity disorder (ADHD) is a recognized medical problem characterized by symptoms of inattention, hyperactivity, and impulsivity. Methylphenidate (MPH Ritalin methyl-alpha-phenyl-2-piperid-inacetate hydrochloride) is prescribed for the treatment of ADHD. MPH has two chiral centers yielding enantiomers with distinct pharmacokinetic and pharmacodynamic properties in humans. It is known that the t/-threo [2R,2 R]-MPH (i.e., (-i-)-threo) exhibits greater pharmacological activity than the... [Pg.625]

Inattention and impulsivity due to attention-deficit/ hyperactivity disorder (ADHD) begins before age 7 and can continue into adolescence and adulthood, often requiring ongoing drug treatment. [Pg.1133]

Pharmacotherapy with stimulants increases dopaminergic and noradrenergic activity, which has the potential to aggravate or precipitate tics. One study examined the comparative effects of methylphenidate and dextroamphetamine on tics in children and found the majority experienced improvement in ADHD symptoms with acceptable effects on tics. Methylphenidate was better tolerated than dextroamphetamine. Another double-blind placebo-controlled trial compared methylphenidate or clonidine monotherapy to combination methylphenidate and clonidine in patients with ADHD and Tourette s disorder. Combination therapy demonstrated the greatest benefit in reducing symptoms of ADHD and tics (p <0.0001). Clonidine appeared most helpful for impulsivity and hyperactivity, while methylphenidate was most helpful for inattention. All treatments were well tolerated. [Pg.1140]

Given the attentional improvement that has been demonstrated with nicotinic receptor stimulation, there are implications for nicotine or novel nicotinic agonists as a possible treatment strategy in attention deficit-hyperactivity disorder (ADHD). This is a disorder primarily of children, but affects adults as well. ADHD afflicts as many as 3-5% of American children (American Psychological Association, 1994) and is characterized by inattention, restlessness, impulsiveness and hyperactivity. There is sig-... [Pg.25]

Corrosion problems in waste heat boilers usually arise either from unusual materials of construction or from inattention to the required details of water treatment. Austenitic stainless steels may be required from the process-side corrosion aspects, yet be highly susceptible to SCC from boiler feedwater. The most frequent problem, however, is that the operating department persoimel, whose primary concern is... [Pg.298]


See other pages where Inattention treatment is mentioned: [Pg.1375]    [Pg.1375]    [Pg.1041]    [Pg.633]    [Pg.234]    [Pg.159]    [Pg.242]    [Pg.264]    [Pg.267]    [Pg.399]    [Pg.485]    [Pg.538]    [Pg.572]    [Pg.189]    [Pg.466]    [Pg.348]    [Pg.1041]    [Pg.3]    [Pg.218]    [Pg.1138]    [Pg.53]    [Pg.249]    [Pg.135]    [Pg.1483]    [Pg.10]   
See also in sourсe #XX -- [ Pg.8 , Pg.21 , Pg.25 , Pg.30 , Pg.34 ]




SEARCH



Inattention

Inattentiveness

© 2024 chempedia.info